| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alzheimer's Association Update
|
|
|
2013
|
9 |
4 |
p. 477-479
3 p.
|
artikel
|
| 2 |
Alzheimer's disease public-private partnerships: A landscape of the global nonprofit community
|
Snyder, Heather M.
|
|
2013
|
9 |
4 |
p. 466-471
6 p.
|
artikel
|
| 3 |
Application of Resource Utilization in Dementia (RUD) instrument in a global setting
|
Wimo, Anders
|
|
2013
|
9 |
4 |
p. 429-435.e17
4.35E19 p.
|
artikel
|
| 4 |
Beyond amyloid: Getting real about nonamyloid targets in Alzheimer's disease
|
Herrup, Karl
|
|
2013
|
9 |
4 |
p. 452-458.e1
4129 p.
|
artikel
|
| 5 |
Biomarker evidence for uncoupling of amyloid build-up and toxicity in Alzheimer's disease
|
Zetterberg, Henrik
|
|
2013
|
9 |
4 |
p. 459-462
4 p.
|
artikel
|
| 6 |
Commentary on “Shining a light on posterior cortical atrophy”
|
Jellinger, Kurt A.
|
|
2013
|
9 |
4 |
p. 475-476
2 p.
|
artikel
|
| 7 |
Contents
|
|
|
2013
|
9 |
4 |
p. A1-A2
nvt p.
|
artikel
|
| 8 |
Designing drug trials for Alzheimer’s disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force
|
Vellas, Bruno
|
|
2013
|
9 |
4 |
p. 438-444
7 p.
|
artikel
|
| 9 |
Editorial Board
|
|
|
2013
|
9 |
4 |
p. A3-
1 p.
|
artikel
|
| 10 |
Hierarchical Bayesian cognitive processing models to analyze clinical trial data
|
Shankle, William R.
|
|
2013
|
9 |
4 |
p. 422-428
7 p.
|
artikel
|
| 11 |
Impact of molecular imaging on the diagnostic process in a memory clinic
|
Ossenkoppele, Rik
|
|
2013
|
9 |
4 |
p. 414-421
8 p.
|
artikel
|
| 12 |
Intersite variability of CSF Alzheimer’s disease biomarkers in clinical setting
|
Dumurgier, Julien
|
|
2013
|
9 |
4 |
p. 406-413
8 p.
|
artikel
|
| 13 |
Leveraging global resources to end the Alzheimer's pandemic
|
Carrillo, Maria C.
|
|
2013
|
9 |
4 |
p. 363-365
3 p.
|
artikel
|
| 14 |
Long-term anticholinergic use and the aging brain
|
Cai, Xueya
|
|
2013
|
9 |
4 |
p. 377-385
9 p.
|
artikel
|
| 15 |
Medical and Scientific Advisory Council
|
|
|
2013
|
9 |
4 |
p. A7-
1 p.
|
artikel
|
| 16 |
Medicare Public Use Files and Alzheimer's disease factors in 2008 and 2010
|
Prada, Sergio Iván
|
|
2013
|
9 |
4 |
p. 472-474
3 p.
|
artikel
|
| 17 |
Military risk factors for Alzheimer's disease
|
Weiner, Michael W.
|
|
2013
|
9 |
4 |
p. 445-451
7 p.
|
artikel
|
| 18 |
New and different approaches needed for the design and execution of Alzheimer's clinical trials
|
Carrillo, Maria C.
|
|
2013
|
9 |
4 |
p. 436-437
2 p.
|
artikel
|
| 19 |
Prevalence of mild cognitive impairment subtypes in patients attending a memory outpatient clinic—comparison of two modes of mild cognitive impairment classification. Results of the Vienna Conversion to Dementia Study
|
Pusswald, Gisela
|
|
2013
|
9 |
4 |
p. 366-376
11 p.
|
artikel
|
| 20 |
Shining a light on posterior cortical atrophy
|
Crutch, Sebastian J.
|
|
2013
|
9 |
4 |
p. 463-465
3 p.
|
artikel
|
| 21 |
β-Site amyloid precursor protein–cleaving enzyme 1 activity is related to cerebrospinal fluid concentrations of sortilin-related receptor with A-type repeats, soluble amyloid precursor protein, and tau
|
Tsolakidou, Amalia
|
|
2013
|
9 |
4 |
p. 386-391
6 p.
|
artikel
|
| 22 |
Subscriber information
|
|
|
2013
|
9 |
4 |
p. A8-
1 p.
|
artikel
|
| 23 |
The influence of insulin infusion on the metabolism of amyloid β peptides in plasma
|
Karczewska-Kupczewska, Monika
|
|
2013
|
9 |
4 |
p. 400-405
6 p.
|
artikel
|
| 24 |
The SIRT2 polymorphism rs10410544 and risk of Alzheimer’s disease in two Caucasian case–control cohorts
|
Polito, Letizia
|
|
2013
|
9 |
4 |
p. 392-399
8 p.
|
artikel
|
| 25 |
Update on appropriate use criteria for amyloid PET imaging: Dementia experts, mild cognitive impairment, and education
|
Johnson, Keith A.
|
|
2013
|
9 |
4 |
p. e106-e109
nvt p.
|
artikel
|
Tijdschrift beschrijving